Jun 28, 2022 | Science, Services
Case Study: Alicanto Discovers High Affinity Rabbit Antibodies to Detect Neurofibromin Researchers at Infixion Bioscience are on a mission to develop new therapeutics for the “orphan disease” neurofibromatosis type 1, which is diagnosed at a rate 1 in 3000 live...
Mar 17, 2022 | Products, Science, Services
Customer Spotlight: Dr. Matthew Burchill Valens™ Rescues Antibody for Liver Disease Research Dr. Matthew Burchill explains how Abterra Bio’s technology, Valens rescued his antibody and enabled him to continue his research in chronic liver disease. “The...
Feb 22, 2022 | Science, Services
Multi-Species Antibody Repertoire Comparison A decade ago, in vivo antibody discovery relied heavily on wild-type mice. Today, it’s not uncommon to generate antibodies using a petting zoo of animals including chicken, goat, rabbit, llamas, alpacas, and humanized...
Nov 16, 2021 | Science, Services
NGS During The Hybridoma Generation Process Next-generation sequencing (NGS) has allowed for unprecedented insights into patterns of the immune response. It can enable high-throughput sequencing of hybridomas as we have discussed in NGS-Enhanced antibody discovery...
Oct 5, 2021 | Science, Services
De Novo Antibody Sequencing Case Study Abterra Bio uses bioinformatics and mass spectrometry to reconstructs the full amino acid sequence of both antibody chains. We’ve successfully sequenced human, mouse, rat, hamster, rabbit, and llama antibodies. This approach can...
Jul 22, 2021 | Publications, Science, Services
New Publication Reveals Ebolavirus-Neutralizing Monoclonal Antibodies Abterra Biosciences, together with VUMC Vaccine Center, Mapp Bio, PNNL, UTMB Health, Ragon Institute, Integral Molecular, and La Jolla Institute, recently published a paper describing the discovery...
